4/A
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001415889-24-026168
Sr. VP and CFO acquired 90,909 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rubin Eyal Sr. VP and CFO | 2024-09-23 | Grant or award | +90,909 | 660,909 | I |
Loading xslF345X05/form4a-11052024_051110.xml…